Shares of Trupanion (TRUP), a leading provider of medical insurance for cats and dogs, surged 8.62% in after-hours trading on Thursday following the release of its first quarter 2025 financial results that exceeded analyst expectations.
The company reported a narrower loss of $0.03 per share, beating the Zacks Consensus Estimate of a $0.04 loss per share. This marked a significant improvement from the $0.16 loss per share recorded in the same quarter last year. Trupanion's revenue for Q1 2025 came in at $341.98 million, surpassing the Zacks Consensus Estimate of $337.8 million and representing an 11.7% year-over-year increase.
Key highlights from Trupanion's Q1 2025 results include: - Total revenue grew 12% year-over-year to $342.0 million - Subscription business revenue increased 16% to $233.1 million - Total enrolled pets reached 1,667,637, with subscription pets growing 5% year-over-year to 1,052,845 - Monthly average revenue per pet rose to $77.53, up from $69.79 in Q1 2024 - Adjusted EBITDA more than doubled to $12.2 million, compared to $4.8 million in Q1 2024 The company's improved financial performance was driven by strong growth in its subscription business and higher average revenue per pet. Trupanion's CEO and President, Margi Tooth, commented on the results, stating, "Q1 was a strong start to the year, with performance ahead of plan across key metrics. We saw early momentum in both retention and pet acquisition, and with expanded margins in our subscription business, we're well-positioned to continue to invest in growth."
Investors reacted positively to Trupanion's ability to narrow its losses while accelerating revenue growth, particularly in its core subscription business. The company's focus on improving operational efficiency and expanding its customer base appears to be paying off, as evidenced by the significant increase in adjusted EBITDA.
Looking ahead, Trupanion's strong Q1 performance and positive outlook may signal continued growth potential in the pet insurance market. As more pet owners prioritize their animals' health, Trupanion's comprehensive medical insurance offerings could see increased demand, potentially driving further improvements in financial results and stock performance.